Portefeuille de l'ETF SURI (NYSE) | MetaTrader

Afficher le graphique complet

Aperçu Toutes les participations Heatmap

Principaux titres en portefeuille Market Value Shares Weight %

United States Treasury Bills 0% 25/06/2026 64.45 M 65.00 M 92.93%

PAGP Plains GP Holdings LP 30.89 M 1.27 M 44.55%

ACHV Achieve Life Science Inc 3.48 M 1.18 M 5.02%

PHAT Phathom Pharmaceuticals Inc 2.92 M 262.39 K 4.20%

DCTH Delcath Systems Inc. 2.42 M 261.13 K 3.49%

ABEO Abeona Therapeutics Inc. 2.24 M 500.34 K 3.23%

CLDX Celldex Therapeutics Inc. 2.19 M 68.99 K 3.16%

MIST Milestone Pharmaceuticals Inc 1.79 M 1.51 M 2.58%

OCS Oculis Holding AG 1.77 M 66.67 K 2.56%

LONA LeonaBio Inc. 1.53 M 149.28 K 2.21%

CORT Corcept Therapeutics Inc. 1.52 M 37.76 K 2.19%

KYTX Kyverna Therapeutics Inc 1.49 M 173.11 K 2.15%

IVA Inventiva SA 1.26 M 227.92 K 1.82%

VRDN Viridian Therapeutics Inc 1.10 M 56.23 K 1.59%

AQST Aquestive Therapeutics Inc 972.26 K 234.28 K 1.40%

VOR VOR BIOPHARMA INC 954.62 K 53.51 K 1.38%

OBIO Orchestra BioMed Holdings Inc 932.39 K 219.39 K 1.34%

ZVRA Zevra Therapeutics Inc 897.01 K 96.25 K 1.29%

CMPS Compass Pathways plc 879.56 K 159.05 K 1.27%

Telesat Canada /Telesat LLC 5.625% 06/12/2026 800.00 K 1.00 M 1.15%

1
2
3

Nouvelles

Obtention de Life Sciences signale les observations de la FDA tout en repoussant le lancement à 2027 pour le médicament de sevrage tabagique | Benzinga France